Cross-Sector entity
market-trends is the sole category represented across all 1 tracked stories. Royal Australian and New Zealand College of Psychiatrists (RANZCP) is most often covered alongside Bilal Cassim, which appears in 1 of these 1 story. Royal Australian and New Zealand College of Psychiatrists (RANZCP) appears in 1 tracked Cross-Sector story from March 20, 2026.
1 verified story tracked
Last mentioned: Mar 20, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. Royal Australian and New Zealand College of Psychiatrists (RANZCP) is most often covered alongside Bilal Cassim, which appears in 1 of these 1 story. Royal Australian and New Zealand College of Psychiatrists (RANZCP) appears in 1 tracked Cross-Sector story from March 20, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Royal Australian and New Zealand College of Psychiatrists (RANZCP). Shared-story counts are live from our verified record — not editorial picks.
The public endorsement of medicinal cannabis by patients like Bilal Cassim for PTSD and insomnia highlights a significant shift in Australian healthcare toward cannabinoid therapies. This trend reflects a broader move toward alternative mental health treatments as the clinical and regulatory landscape continues to evolve.
